IPCA Laboratories Limited
HDFC Life Insurance decreased its stake in IPCA Laboratories Limited from 1.56% to 1.39%, selling 429,112 shares. The value of the shares sold is ₹82.3 Cr at a price of ₹1920.40 apiece.
A pharmaceutical manufacturer and marketer, Ipca Labs produces a wide range of medicines across therapeutic areas including antimalarials, anti-infectives, gastrointestinal treatments, and gynecological formulations. The company operates manufacturing facilities across India and exports its products to international markets. Its distinctive strength lies in its expertise in complex drug formulations, established distribution networks across Indian states, and a focus on affordable healthcare solutions for domestic and global markets.
HDFC Life Insurance Company Limited, institutional investor in Indian equities